RBC Capital Believes Anthem Inc (NYSE: ANTM) Still Has Room to Grow

By Jason Carr

RBC Capital analyst Frank Morgan reiterated a Buy rating on Anthem Inc (NYSE: ANTM) today and set a price target of $183. The company’s shares opened today at $183.32, close to its 52-week high of $185.

According to TipRanks.com, Morgan is a 5-star analyst with an average return of 12.7% and a 64.0% success rate. Morgan covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care Corp, Quest Diagnostics Inc, and Surgery Partners Inc.

Anthem Inc has an analyst consensus of Moderate Buy, with a price target consensus of $189.43.

Anthem Inc’s market cap is currently $48.53B and has a P/E ratio of 17.76. The company has a book value ratio of 1.8600.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through three segments: Commercial and Specialty Business, Government Business and Other. The Commercial and Specialty Business segment includes local group, national accounts, and individual and specialty businesses. The Government Business segment includes medi care and medic aid businesses, national government services and services provided to the federal government in connection with federal employee program. The Other segment includes other businesses that do not meet the quantitative thresholds for an operating segment as defined by financial accounting standards board guidance, as well as corporate expenses not allocated to the other reportable segments. The company was founded on November 30, 2004 and is headquartered in Indianapolis, IN.